使用查数据与干预后审查进行多状态癌症进展建模方法的比较
Eddymurphy U Akwiwu1, Veerle M H Coupé1, Johannes Berkhof1
1Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.
概括
这项研究比较了多州癌症模型的查和监测数据. 贝叶斯TSM方法证明了可靠的风险估计,特别是当癌症前体进展的危险性取决于时间时.
科学领域:
- 生物统计学 生物统计学
- 癌症流行病学 癌症流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 精确的癌症查和监测依赖于了解住院时间和从前恶性病变引起的癌症风险.
- 多州癌症模型估计了这些参数,但当治疗前体时,它们的表现不足,防止癌症进展 (审查设置).
- 这项研究探讨了在这种特定的审查场景中多状态方法的性能.
研究的目的:
- 评估各种多状态癌症建模方法在癌症前体检测后进行治疗的环境中的性能.
- 确定哪些方法在不同的危险假设下提供无偏见的风险估计 (时间独立与时间依赖).
主要方法:
- 我们比较了6个R软件包实现的多状态模型 (msm,cthmm,smms,BayesTSM,hmm).
- 评估的模型具有时间独立的危险和危险取决于从状态进入或过程开始以来的时间.
- 通过模拟和应用对结直肠癌监测数据 (健康,非晚期腺瘤,晚期瘤状态) 评估模型性能.
主要成果:
- 所有的方法都在模拟中表现得很好,具有时间独立的危险.
- 只有smms和BayesTSM在危险取决于进入状态后的时间时,才产生了公正的风险估计.
- 在结直肠癌数据应用中,只有msm,hmm和BayesTSM趋同;BayesTSM和hmm显示了类似的非先进腺瘤风险估计,而先进瘤风险估计有所不同.
结论:
- 危害的时间依赖性显著影响多种癌症模型的性能,特别是对于不可观察的前体到癌症的过渡.
- 贝叶斯TSM提供了可靠和公正的风险估计,特别是在现实的场景中,自进入状态以来的危险取决于时间.
- 选择多状态建模方法至关重要,以避免在癌症查和监测分析中偏见的参数估计.
相关概念视频
Censoring Survival Data
626
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
626
Comparing the Survival Analysis of Two or More Groups
687
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
687
Cancer Survival Analysis
811
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811
Kaplan-Meier Approach
687
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
687
Assumptions of Survival Analysis
473
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
473
Introduction To Survival Analysis
913
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
913


